Fabric

Login
Register

- Login
- Register

5015 Objects

About
Browse
- Objects
  Analytics

Analytics
Research
Contact
Decimal

16 Object Results
Filter results

Add all results to lightbox
Select results to add to lightbox
Sort by:

Date

Title

Sort order:

Ascending
Descending

Start Over

Download results as:

Checklist
PDF (thumbnails)
Excel (basic information)
PowerPoint (basic information)

Marketing:

Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health

Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health

Computer Guts and Swallowed Sensors: Ingestibles Made Palatable in an Era of Embodied Computing

etectRx's ingestible adherence tracker system cleared by FDA

etectRx's ingestible adherence tracker system cleared by FDA

Ethical and legal issues of ingestible electronic sensors

Ethical and legal issues of ingestible electronic sensors

The Promise and Pitfalls of Digital Medication

Take Your Medicine: This $1.5 Billion Health Startup’s Smart Pills Keep Patients From Forgetting

Take Your Medicine: This $1.5 Billion Health Startup’s Smart Pills Keep Patients From Forgetting

Final Proteus Letter to the Federal Communications Commission

Final Proteus Letter to the Federal Communications Commission

The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine

General Session: Andrew Thompson, Proteus Digital Health and Kabir Nath, Otsuka Pharmaceutical

Abilify MyCite Patient Terms of Use and Privacy Notice

Abilify MyCite Patient Terms of Use and Privacy Notice

Abilify MyCite® Overview

Abilify MyCite® Overview

Otsuka and Proteus® Announce the First U.S. FDA Approval of a Digital Medicine System: Abilify MyCite® (aripiprazole tablets with sensor)

Otsuka and Proteus® Announce the First U.S. FDA Approval of a Digital Medicine System: Abilify MyCite® (aripiprazole tablets with sensor)

First Digital Pill Approved to Worries About Biomedical ‘Big Brother’

First Digital Pill Approved to Worries About Biomedical ‘Big Brother’

FDA Approval Letter Abilify MyCite (aripiprazole)

FDA Approval Letter Abilify MyCite (aripiprazole)

The digitization of a pill

The frightening promise of self-tracking pills

Filter by

HCI Platform

Relation to body

Discursive Type

A Response to an Invention

Persuasive Type

Media Type

Loading...

collection

Policy and Privacy Implications of Ingestibles (2020-2021)

Related Body Part

Digestive tract

Augments

People/Companies/Related Entities

Ameet Sarpatwari

Andrew Thompson

Brigham and Women's Hospital

Columbia University

Duke University

Federal Communications Commission (FCC)

Food and Drug Administration (FDA)

Forbes Media LLC

Harvard Business School

Harvard Medical School

Jeffrey Lieberman

Jobson Medical Information LLC

Jonathan Watanabe

Marlene H. Dortch

New York University (NYU)

Niteesh K. Chouhdry

Otsuka Pharmaceutical

Proteus Digital Health

Royal Melbourne Institute of Technology (RMIT University)

Russell Brandom

Scripps Translational Science Institute

Springer Nature Publishing

Taylor & Francis Group

Temple University

The Center for Drug Evaluation and Research

The New York Times Company

University Of California At San Diego

University Of Pittsburgh Medical Center UPMC

Technology

Activity Trackers

Artificial Intelligence (AI)

Digital Medicine

Embodied Computing

Embodied Interaction

Glucose Monitors

Ingestible Adherence Tracking System

Ingestible Capsules

Ingestible Electronic Devices

Ingestible Event Marker (IEM) Sensor

Ingestible Sensors

Ingestible electronic sensors

Medicine Tracking

Remote Monitoring

Remote Patient Monitoring

Smartphone Applications

Trackable Pills

Ubiquitous Computing

Wearable sensors

Wireless Connectivity

Marketing

Connect2HealthFCC

Dexcom G6 Continuous Glucose Monitor

Embodied Computing: Wearables, Implantables, Embeddables, Ingestibles

Fantastic Voyage

HLTH Conference

Keratin Biosciences

Otsuka Pharmaceutical

Proteus Digital Health

Proteus Discover

The Future of Medicine is Digital

Keyword

Pharmaceuticals

Terms of Service

title

Abilify MyCite Patient Terms of Use and Privacy Notice

Abilify MyCite® Overview

Computer Guts and Swallowed Sensors: Ingestibles Made Palatable in an Era of Embodied Computing

EtectRx's ingestible adherence tracker system cleared by FDA

Ethical and legal issues of ingestible electronic sensors

FDA Approval Letter Abilify MyCite (aripiprazole)

Final Proteus Letter to the Federal Communications Commission

First Digital Pill Approved to Worries About Biomedical ‘Big Brother’

General Session: Andrew Thompson, Proteus Digital Health and Kabir Nath, Otsuka Pharmaceutical

Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health

Otsuka and Proteus® Announce the First U.S. FDA Approval of a Digital Medicine System: Abilify MyCite® (aripiprazole tablets with sensor)

Take Your Medicine: This $1.5 Billion Health Startup’s Smart Pills Keep Patients From Forgetting

The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine

The Promise and Pitfalls of Digital Medication

The digitization of a pill

The frightening promise of self-tracking pills

Publication Title

Embodied Computing: Wearables, Implantables, Embeddables, Ingestibles

Harvard Business School

Nature Electronics

New Media & Society

Otsuka Pharmaceutical

Proteus Digital Health

The American Journal of Bioethics

The New York Times

U.S. Pharmacist

© 2023 Decimal Lab

powered by CollectiveAccess 2023